Mayo Clinic and the University of Minnesota will try and raise at least $250m to research diabetes and offer corporate venturing opportunities to local companies.
Two US-based diabetes research centres are expected to raise $250m to $350m to invest in diabetes treatments with the opportunity to take minority stakes in the nascent companies formed as a result of their work.
Mayo Clinic and the University of Minnesota will try and raise and invest the money over the next 10 years, according to local news provider MedCityNews.
Vance Opperman, executive president of local asset manager Key Investments, is on the committee for the partnership project called…
